Meeting
2018 Genitourinary Cancers Symposium
Vascular and tumor cell expression of VEGFR2 and molecular subtyping: An innovative biomarker approach in bladder cancer.
Authors
Aejaz Nasir
Eli Lilly and Company, Indianapolis, IN
Aejaz Nasir , Beverly L Falcon , Dan Wang , Timothy R. Holzer , Elizabeth M Nonte , Mia Yang Chen , Angie D Fulford , Julia H Carter , Larry E Douglass , Bronislaw Pytowski , Katherine M Bell-McGuinn , Richard A. Walgren , Andrew E Schade , Aafia Chaudhry
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral, and Testicular Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 497)
DOI
10.1200/JCO.2018.36.6_suppl.497
Abstract #
497
Poster Bd #
K4
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Immunohistochemical (IHC) subtypes of metastatic bladder cancer (mBC) using GATA3 and CK5/6.
First Author: Ariel Ann Nelson
Poster
2022 ASCO Genitourinary Cancers Symposium
Evaluating therapeutic bladder cancer trial disparities in race/ethnicity.
First Author: Ishaan Iyer
Poster
2022 ASCO Genitourinary Cancers Symposium
Identification of muscle-invasion status in bladder cancer patients using natural language processing and machine learning.
First Author: Ruixin Yang
Poster
2021 Genitourinary Cancers Symposium
Transcriptome analysis of low-risk and high-risk non-muscular invasive bladder cancer patients to reveal disease progression related genes.
First Author: Zhichao Fu